Relationship between the intratumor pharmacokinetics and antitumor effect of the payload eribulin in the novel antibody-drug conjugate MORAb-202

被引：0
|
作者：
Koganemaru, S. [1 ]
Fuchigami, H. [2 ]
Tsugawa, H. [2 ]
Kuboki, Y. [1 ]
Furuuchi, K. [3 ]
Uenaka, T. [3 ]
Doi, T. [1 ]
Yasunaga, M. [2 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Expt Therapeut, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan
[3] Eisai Inc, Epochal Precis Anticanc Therapeut EPAT, Exton, PA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 174卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
242
引用
收藏
页码：S87 / S87
页数：1
相关论文
共 50 条
  • [41] Rational Identification of Novel Antibody-Drug Conjugate with High Bystander Killing Effect against Heterogeneous Tumors
    Guo, Yu
    Shen, Zheyuan
    Zhao, Wenbin
    Lu, Jialiang
    Song, Yi
    Shen, Liteng
    Lu, Yang
    Wu, Mingfei
    Shi, Qiuqiu
    Zhuang, Weihao
    Qiu, Yueping
    Sheng, Jianpeng
    Zhou, Zhan
    Fang, Luo
    Che, Jinxin
    Dong, Xiaowu
    ADVANCED SCIENCE, 2024, 11 (13)
  • [42] U3-1402, a novel HER3-targeting antibody-drug conjugate, exhibits its antitumor activity through increased payload intracellular delivery via highly efficient drug internalization
    Koyama, Kumiko
    Hashimoto, Yuuri
    Kamai, Yasuki
    Shiose, Yoshinobu
    Abe, Manabu
    Kaneda, Yuki
    Maeda, Naoyuki
    Hirotani, Kenji
    Ogitani, Yusuke
    Karibe, Tsuyoshi
    Kagari, Takashi
    Wakita, Kenichi
    Ueno, Suguru
    Agatsuma, Toshinori
    Murakami, Masato
    CANCER RESEARCH, 2019, 79 (13)
  • [43] A novel enediyne-integrated antibody-drug conjugate shows promising antitumor efficacy against CD30+ lymphomas
    Wang, Rong
    Li, Liang
    Zhang, Shenghua
    Li, Yi
    Wang, Xiaofei
    Miao, Qingfang
    Zhen, Yongsu
    MOLECULAR ONCOLOGY, 2018, 12 (03) : 339 - 355
  • [44] Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells
    Okajima, Daisuke
    Yasuda, Satoru
    Maejima, Takanori
    Karibe, Tsuyoshi
    Sakurai, Ken
    Aida, Tetsuo
    Toki, Tadashi
    Yamaguchi, Junko
    Kitamura, Michiko
    Kamei, Reiko
    Fujitani, Tomomichi
    Honda, Tomoyo
    Shibutani, Tomoko
    Muramatsu, Sumie
    Nakada, Takashi
    Goto, Riki
    Takahashi, Shu
    Yamaguchi, Miki
    Hamada, Hirofumi
    Noguchi, Yutaka
    Murakami, Masato
    Abe, Yuki
    Agatsuma, Toshinori
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12) : 2329 - 2340
  • [45] OBI-992, a Novel TROP2-Targeted Antibody-Drug Conjugate, Demonstrates Antitumor Activity in Multiple Cancer Models
    Li, Wan-Fen
    Chiang, Ming-Feng
    Weng, Hao-Cheng
    Yang, Jhih-Jie
    Wu, Hsin-Shan
    Wu, Szu-Yu
    Chen, Yu-Jung
    Lu, Chi-Huan
    Tu, Jyy-Shiuan
    Hsu, Ren-Yu
    Shia, Chi-Sheng
    Huang, Teng-Yi
    Lai, Ming-Tain
    MOLECULAR CANCER THERAPEUTICS, 2025, 24 (02) : 163 - 175
  • [46] EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF BRENTUXIMAB VEDOTIN, AN ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH CD30-POSITIVE HEMATOLOGIC MALIGNANCIES
    Han, T. H.
    Grove, L. E.
    Lynch, C. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S17 - S18
  • [47] EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma
    Capone, Emily
    Giansanti, Francesco
    Ponziani, Sara
    Lamolinara, Alessia
    Iezzi, Manuela
    Cimini, Annamaria
    Angelucci, Francesco
    La Sorda, Rossana
    De laurenzi, Vincenzo
    Natali, Pier Giorgio
    Ippoliti, Rodolfo
    Iacobelli, Stefano
    Sala, Gianluca
    ONCOTARGET, 2017, 8 (56) : 95412 - 95424
  • [48] Selectivity and Safety of VIP943: A Novel CD123-Targeting Antibody-Drug Conjugate (ADC) Using a Proprietary Linker and Payload Class
    Stelte-Ludwig, Beatrix
    Schomber, Tibor
    Izumi, Raquel
    Wong, Harvey
    Frigault, Melanie M.
    Rebstock, Anne-Sophie
    Ludwig, Sebastian
    Mithal, Arushi
    Johnson, Amy J.
    Hamdy, Ahmed
    BLOOD, 2023, 142
  • [49] A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma
    Hoffmann, Ricarda M.
    Crescioli, Silvia
    Mele, Silvia
    Sachouli, Eirini
    Cheung, Anthony
    Chui, Connie K.
    Andriollo, Paolo
    Jackson, Paul J. M.
    Lacy, Katie E.
    Spicer, James F.
    Thurston, David E.
    Karagiannis, Sophia N.
    CANCERS, 2020, 12 (04)
  • [50] Antitumor effect of HER3-DXd, an antibody-drug conjugate targeting HER3, in gastric cancer cell lines
    Hwang, Hae Min
    Kim, So Hyeon
    Ham, Sujin
    Lee, Minyoung
    Noh, Youlim
    Kim, Yu-Jin
    Lee, Changyun
    Kim, Jinyoung
    Lee, Dae-Won
    Lee, Kyung-Hun
    Im, Seock-Ah
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
12345